Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial

Shruti K. Gohil, Edward Septimus, Ken Kleinman, Neha Varma, Taliser R. Avery, Lauren Heim, Risa Rahm, William S. Cooper, Mandelin Cooper, Laura E. McLean, Naoise G. Nickolay, Robert A. Weinstein, L. Hayley Burgess, Micaela H. Coady, Edward Rosen, Selsebil Sljivo, Kenneth E. Sands, Julia Moody, Justin Vigeant, Syma RashidRebecca F. Gilbert, Kim N. Smith, Brandon Carver, Russell E. Poland, Jason Hickok, S. G. Sturdevant, Michael S. Calderwood, Anastasiia Weiland, David W. Kubiak, Sujan Reddy, Melinda M. Neuhauser, Arjun Srinivasan, John A. Jernigan, Mary K. Hayden, Abinav Gowda, Katyuska Eibensteiner, Robert Wolf, Jonathan B. Perlin, Richard Platt, Susan S. Huang

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Importance: Urinary tract infection (UTI) is the second most common infection leading to hospitalization and is often associated with gram-negative multidrug-resistant organisms (MDROs). Clinicians overuse extended-spectrum antibiotics although most patients are at low risk for MDRO infection. Safe strategies to limit overuse of empiric antibiotics are needed. Objective: To evaluate whether computerized provider order entry (CPOE) prompts providing patient-and pathogen-specific MDRO risk estimates could reduce use of empiric extended-spectrum antibiotics for treatment of UTI. Design, Setting, and Participants: Cluster-randomized trial in 59 US community hospitals comparing the effect of a CPOE stewardship bundle (education, feedback, and real-Time and risk-based CPOE prompts; 29 hospitals) vs routine stewardship (n = 30 hospitals) on antibiotic selection during the first 3 hospital days (empiric period) in noncritically ill adults (≥18 years) hospitalized with UTI with an 18-month baseline (April 1, 2017-September 30, 2018) and 15-month intervention period (April 1, 2019-June 30, 2020). Interventions: CPOE prompts recommending empiric standard-spectrum antibiotics in patients ordered to receive extended-spectrum antibiotics who have low estimated absolute risk (<10%) of MDRO UTI, coupled with feedback and education. Main Outcomes and Measures: The primary outcome was empiric (first 3 days of hospitalization) extended-spectrum antibiotic days of therapy. Secondary outcomes included empiric vancomycin and antipseudomonal days of therapy. Safety outcomes included days to intensive care unit (ICU) transfer and hospital length of stay. Outcomes were assessed using generalized linear mixed-effect models to assess differences between the baseline and intervention periods. Results: Among 127403 adult patients (71991 baseline and 55412 intervention period) admitted with UTI in 59 hospitals, the mean (SD) age was 69.4 (17.9) years, 30.5% were male, and the median Elixhauser Comorbidity Index count was 4 (IQR, 2-5). Compared with routine stewardship, the group using CPOE prompts had a 17.4% (95% CI, 11.2%-23.2%) reduction in empiric extended-spectrum days of therapy (rate ratio, 0.83 [95% CI, 0.77-0.89]; P <.001). The safety outcomes of mean days to ICU transfer (6.6 vs 7.0 days) and hospital length of stay (6.3 vs 6.5 days) did not differ significantly between the routine and intervention groups, respectively. Conclusions and Relevance: Compared with routine stewardship, CPOE prompts providing real-Time recommendations for standard-spectrum antibiotics for patients with low MDRO risk coupled with feedback and education significantly reduced empiric extended-spectrum antibiotic use among noncritically ill adults admitted with UTI without changing hospital length of stay or days to ICU transfers. Trial Registration: ClinicalTrials.gov Identifier: NCT03697096.

Original languageEnglish (US)
Pages (from-to)2018-2028
Number of pages11
JournalJAMA: The Journal of the American Medical Association
Volume331
Issue number23
DOIs
StatePublished - Jun 2024

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial'. Together they form a unique fingerprint.

Cite this